Cargando…
Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies
More than a century after its first description, Langerhans cell histiocytosis (LCH) still remains an intriguing disease. Considerable progress in understanding its biology has been achieved recently. Description of the V600E BRAF mutation in samples of LCH tissue in 2010 was followed by description...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066850/ https://www.ncbi.nlm.nih.gov/pubmed/27785447 http://dx.doi.org/10.2147/ITT.S91058 |